Volume 5, Supplement 5SupplementLong-Term Experience With 5-Alpha-Reductase InhibitorsE Darracott VaughanBenign prostatic hyperplasiaFinasterideDihydrotestosterone
Volume 5, Supplement 4SupplementLong-Term Experience with 5-Alpha-Reductase InhibitorsE Darracott VaughanBenign prostatic hyperplasiaFinasterideDihydrotestosterone
Volume 5, Supplement 1SupplementAndrogen Supplementation and Prostate Cancer Risk: Strategies for Pretherapy Assessment and MonitoringMichael K BrawerProstate cancerProstate-specific antigenHypogonadismDihydrotestosteroneAndrogen replacement5-Alpha-reductase
Volume 6, Supplement 9SupplementRole of Primary Care Clinicians in the Diagnosis and Treatment of LUTS and BPHLouis KuritzkyLower urinary tract symptoms5-reductase inhibitorsBenign prostatichyperplasiaDihydrotestosteronePrimary care clinicians
Volume 6, Supplement 9SupplementComparison of Clinical Trials With Finasteride and DutasterideJ Curtis NickelBenign prostatic hyperplasiaMedical therapyFinasterideDutasterideDihydrotestosterone5-reductase
Volume 6, Supplement 9Supplement5-Alpha-Reductase: History and Clinical ImportanceLeonard S MarksBenign prostatic hyperplasiaFinasterideDutasterideDihydrotestosterone5-reductaseGuevedoces
Volume 6, Supplement 7SupplementChallenges with Luteinizing Hormone-Releasing Hormone Agonists: Flare and SurgeMichael K BrawerLuteinizing hormone releasing hormoneDihydrotestosteroneFlareProstatic